124 related articles for article (PubMed ID: 18182398)
1. Association of cyclin D1 G870A polymorphism with uterine leiomyoma in women whose body mass index values are above 25 kg/m2.
Han SS; No JH; Jeon YT; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Hum Reprod; 2008 Mar; 23(3):525-9. PubMed ID: 18182398
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 G870A polymorphism: Association with uterine leiomyoma risk and
Salimi S; Shahrakipour M; Hajizadeh A; Mokhtari M; Mousavi M; Teimoori B; Yaghmaei M
Biomed Rep; 2017 Feb; 6(2):237-241. PubMed ID: 28357079
[TBL] [Abstract][Full Text] [Related]
3. DNA repair gene XRCC1 Arg399Gln polymorphism is associated with increased risk of uterine leiomyoma.
Jeon YT; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Hum Reprod; 2005 Jun; 20(6):1586-9. PubMed ID: 15760950
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
[TBL] [Abstract][Full Text] [Related]
5. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer.
Yuan L; Gu X; Shao J; Wang M; Wang M; Zhu Q; Zhang Z
DNA Cell Biol; 2010 Oct; 29(10):611-7. PubMed ID: 20575692
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 G870A polymorphism and squamous cell carcinoma of the uterine cervix in Korean women.
Jeon YT; Kim JW; Song JH; Park NH; Song YS; Kang SB; Lee HP
Cancer Lett; 2005 Jun; 223(2):259-63. PubMed ID: 15896460
[TBL] [Abstract][Full Text] [Related]
8. AA genotype of cyclin D1 G870A polymorphism increases breast cancer risk: Findings of a case-control study and meta-analysis.
Akhter N; Alzahrani FA; Dar SA; Wahid M; Sattar RSA; Hussain S; Haque S; Ansari SA; Jawed A; Mandal RK; Almalki S; Alharbi RA; Husain SA
J Cell Biochem; 2019 Oct; 120(10):16452-16466. PubMed ID: 31243808
[TBL] [Abstract][Full Text] [Related]
9. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.
Zeng Z; Tu J; Cheng J; Yao M; Wu Y; Huang X; Xie X; Zhang X; Lu F; Chen X
Tumour Biol; 2015 Sep; 36(9):6891-900. PubMed ID: 25851350
[TBL] [Abstract][Full Text] [Related]
10. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
Hu Z; Zhou Z; Xiong G; Wang Y; Lai Y; Deng L; Yang J
Tumour Biol; 2014 Jun; 35(6):5607-12. PubMed ID: 24570185
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in genes HSD17B1 and HSD17B2 and uterine leiomyoma risk in Chinese women.
Cong RJ; Huang ZY; Cong L; Ye Y; Wang Z; Zha L; Cao LP; Su XW; Yan J; Li YB
Arch Gynecol Obstet; 2012 Sep; 286(3):701-5. PubMed ID: 22546946
[TBL] [Abstract][Full Text] [Related]
13. The effects of p21 gene C98A polymorphism on development of uterine leiomyoma in southeast Iranian women.
Salimi S; Hajizadeh A; Yaghmaei M; Rezaie S; Shahrakypour M; Teimoori B; Parache M; Naghavi A; Mokhtari M
Tumour Biol; 2016 Sep; 37(9):12497-12502. PubMed ID: 27337955
[TBL] [Abstract][Full Text] [Related]
14. Association of cyclin D1 G870A polymorphism with susceptibility to gastric cancers in Korean male patients.
Song JH; Kim CJ; Cho YG; Park YK; Nam SW; Yoo NJ; Lee JY; Park WS
Neoplasma; 2007; 54(3):235-9. PubMed ID: 17447856
[TBL] [Abstract][Full Text] [Related]
15. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.
Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S
J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525
[TBL] [Abstract][Full Text] [Related]
16. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
Hu YY; Zheng R; Guo C; Niu YM
Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
[TBL] [Abstract][Full Text] [Related]
18. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
[TBL] [Abstract][Full Text] [Related]
20. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
Xie M; Zhao F; Zou X; Jin S; Xiong S
Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
